MedPath

The Effect of Antihypertensive Medication Timing on Morbidity and Mortality

Phase 4
Completed
Conditions
Hypertension
Registration Number
NCT02990663
Lead Sponsor
University of Alberta
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
3357
Inclusion Criteria

Inclusion Criteria:<br><br> 1. Hypertension diagnosis as assigned by a physician or nurse practitioner<br><br> 2. = 1 blood pressure medication taken once daily, or primary care provider willing to<br> convert = 1 blood pressure medication to once daily<br><br> 3. Community dwelling (i.e. not residing in a nursing home; assisted living permitted)<br><br>Exclusion Criteria:<br><br> 1. Palliative (as per primary care provider's judgement)<br><br> 2. Unable to provide informed consent (as per primary care provider's judgement)<br><br> 3. Personal history of glaucoma or use of glaucoma medications<br><br> 4. Sleep disrupting shift work (more than 3 shifts/month during participant's regular<br> sleeping hours)

Exclusion Criteria

Not provided

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Major Adverse Cardiovascular Events
Secondary Outcome Measures
NameTimeMethod
All-cause mortality;Acute coronary syndrome;CHF Hospitalization;Stoke;All-cause hospitalization;Long term care admission;New glaucoma diagnosis;Non-vertebral fracture;Cognitive decline
© Copyright 2025. All Rights Reserved by MedPath